Palatin Technologies, Inc.

PTNAMEXUSD
18.49 USD
4.29 (20.90%)🟢PRE MARKET (AS OF 04:39 AM EDT)
🟢Market: OPEN
Open?$20.08
High?$20.08
Low?$16.20
Prev. Close?$20.49
Volume?2
Avg. Volume?15.7K
VWAP?$20.08
Rel. Volume?0.00x
Bid / Ask
Bid?$18.66 × 100
Ask?$21.18 × 100
Spread?$2.52
Midpoint?$19.92
Valuation & Ratios
Market Cap?36.3M
Shares Out?1.8M
Float?1.7M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?3.17
EPS?-$5.43
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.76Strong
Quick Ratio?2.76Strong
Cash Ratio?2.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
3.17FAIR
P/S?
4.05FAIR
P/FCF?
N/A
EV/EBITDA?
-1.8CHEAP
EV/Sales?
2.44CHEAP
Returns & Efficiency
ROE?
-84.0%WEAK
ROA?
-53.7%WEAK
Cash Flow & Enterprise
FCF?$-15882361
Enterprise Value?$21.8M
Related Companies
Loading...
News
Profile
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Employees
29
Market Cap
31.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1993-11-04
Address
4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Phone: 609-495-2200